Early detection of complications in pancreas transplants by microdialysis catheters, an observational feasibility study

PLoS One. 2021 Mar 11;16(3):e0247615. doi: 10.1371/journal.pone.0247615. eCollection 2021.

Abstract

Background: Despite advances in immunosuppression and surgical technique, pancreas transplantation is encumbered with a high rate of complication and graft losses. Particularly, venous graft thrombi occur relatively frequently and are rarely detected before the transplant is irreversibly damaged.

Methods: To detect complications early, when the grafts are potentially salvageable, we placed microdialysis catheters anteriorly and posteriorly to the graft in a cohort of 34 consecutive patients. Glucose, lactate, pyruvate, and glycerol were measured at the bedside every 1-2 hours.

Results: Nine patients with graft venous thrombosis had significant lactate and lactate-to-pyruvate-ratio increases without concomitant rise in blood glucose or clinical symptoms. The median lactate in these patients was significantly higher in both catheters compared to non-events (n = 15). Out of the nine thrombi, four grafts underwent successful angiographic extraction, one did not require intervention and four grafts were irreversibly damaged and explanted. Four patients with enteric anastomosis leakages had significantly higher glycerol measurements compared to non-events. As with the venous thrombi, lactate and lactate-to-pyruvate ratio were also increased in six patients with graft surrounding hematomas.

Conclusions: Bedside monitoring with microdialysis catheters is a promising surveillance modality of pancreatic grafts, but differentiating between the various pathologies proves challenging.

Publication types

  • Clinical Trial
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antilymphocyte Serum / therapeutic use
  • Catheters, Indwelling
  • Early Diagnosis
  • Feasibility Studies
  • Female
  • Glucose / metabolism
  • Glycerol / metabolism
  • Graft Rejection / diagnosis*
  • Graft Rejection / immunology
  • Graft Rejection / metabolism
  • Hematoma / diagnosis*
  • Hematoma / etiology
  • Hematoma / immunology
  • Hematoma / metabolism
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lactic Acid / metabolism
  • Male
  • Microdialysis / instrumentation
  • Microdialysis / methods*
  • Middle Aged
  • Monitoring, Physiologic / methods*
  • Mycophenolic Acid / therapeutic use
  • Pancreas Transplantation / adverse effects*
  • Pyruvic Acid / metabolism
  • Tacrolimus / therapeutic use
  • Venous Thrombosis / diagnosis*
  • Venous Thrombosis / etiology
  • Venous Thrombosis / immunology
  • Venous Thrombosis / metabolism

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Lactic Acid
  • Pyruvic Acid
  • Mycophenolic Acid
  • Glucose
  • Glycerol
  • Tacrolimus

Grants and funding

This work was supported by an unrestricted research grant from South-Eastern Norway Regional Health Authority (2016028).